Citation: K. Welt et al., Experimental hypoxia of STZ-diabetic rat myocardium and protective effectsof Ginkgo biloba extract - II. Ultrastructural investigation of microvascular endothelium, EXP TOX PAT, 52(6), 2001, pp. 503-512
Authors:
Fitzl, G
Welt, K
Wassilew, G
Clemens, N
Penka, K
Mukke, N
Citation: G. Fitzl et al., The influence of hypoxia on the myocardium of experimentally diabetic ratswith and without protection by Ginkgo biloba extract - III: Ultrastructural investigations on mitochondria, EXP TOX PAT, 52(6), 2001, pp. 557-568
Authors:
Fitzl, G
Welt, K
Martin, R
Dettmer, D
Hermsdorf, T
Clemens, N
Konig, S
Citation: G. Fitzl et al., The influence of hypoxia on the myocardium of experimentally diabetic ratswith and without protection by Ginkgo biloba extract I. Ultrastructural and biochemical investigations on cardiomyocytes, EXP TOX PAT, 52(5), 2000, pp. 419-430
Citation: K. Welt et al., Lipoxygenase inhibitor FLM 5011, an effective protectant of myocardial microvessels against ischemia-reperfusion injury? An ultrastructural-morphometric study, EXP TOX PAT, 52(1), 2000, pp. 27-36
Authors:
Fitzl, G
Martin, R
Dettmer, D
Hermsdorf, V
Drews, H
Welt, K
Citation: G. Fitzl et al., Protective effects of Ginkgo biloba extract EGb 761 on myocardium of experimentally diabetic rats - I: Ultrastructural and biochemical investigation on cardiomyocytes, EXP TOX PAT, 51(3), 1999, pp. 189-198
Citation: K. Welt et al., Protective effects of Ginkgo biloba extract EGb 761 on the myocardium of experimentally diabetic rats - II. Ultrastructural and immunohistochemical investigation on microvessels and interstitium, EXP TOX PAT, 51(3), 1999, pp. 213-222
Citation: G. Fitzl et al., The protective effect of lipoxygenase inhibitor FLM 5011 on mitochondria ultrastructure of ischemic and reperfused cardiomyocytes, EXP TOX PAT, 51(3), 1999, pp. 245-253
Citation: G. Fitzl et al., The protective effect of Iloprost, a PGL2-analogue, on ultrastructure of ischemic and reperfused myocardial myocytes, EXP TOX PAT, 51(1), 1999, pp. 81-88